Pharmaceutical patent issues : interpreting GATT : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, second session, on examining the interrelationship between the intellectual property provisions of the GATT treaty implementing law and food and drug law and its impact on the creation of new breakthrough drugs and production of lower generic copies, and S. 1277, a bill to provide equitable relief for the generic drug industry, and for other purposes, February 27, and March 5, 1996.

Author/creator United States
Format Book
Publication InfoWashington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1997.
Descriptionvi, 291 pages : illustrations ; 24 cm.
Subjects

SeriesS. hrg. ; 104-878
United States. Congress. Senate. S. hrg. ; 104-878. ^A500722
General noteDistributed to some depository libraries in microfiche.
General noteShipping list no.: 98-0061-P.
General note"Serial no. J-104-65."
Bibliography noteIncludes bibliographical references.
Issued in other formOnline version: United States. Congress. Senate. Committee on the Judiciary. Pharmaceutical patent issues. Washington : U.S.G.P.O. : For sale by the U.S.G.P.O., Supt. of Docs., Congressional Sales Office, 1997
LCCN 98132584
ISBN0160557097
ISBN9780160557095
Technical rpt numberSerial no. J-104-65 (United States. Congress. Senate. Committee on the Judiciary)
GPO item number1042-A
GPO item number1042-B (MF)
Govt. docs number Y 4.J 89/2:S.HRG.104-878

Availability

Library Location Call Number Status Item Actions
Joyner Fed Docs Stacks Y 4.J 89/2:S.HRG.104-878 ✔ Available Place Hold